Delivery Order SPE2DB22D1002-SPE2DB25FKXN3

Award Date 2/3/25
Potential Completion Date 2/4/25
Potential Value $4.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,714.49 firm fixed-price delivery order is for the supply of JARDIANCE 10 MG TABLET 90S, a medication used for diabetes management. The contract has an ultimate completion date of April 1, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,208.68 delivery order contract is for the supply of JARDIANCE 10 MG TABLET 90S, a medication used to treat diabetes. The contract has a firm fixed price and a period of performance running through June 5, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,447.31, is a delivery order for the supply of JARDIANCE 25 MG TABLET 90S, a medication used to treat diabetes. The contract has a firm fixed price structure and an ultimate completion date of November 21, 2024. This contract award is associated with a larger Indefinite Delivery Contract...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $44,093.18, is for the delivery of JARDIANCE 25 MG TABLET 90S, a medication used to treat diabetes. The contract has an ultimate completion date of January 14, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,084.26 firm fixed-price delivery order is for the supply of JARDIANCE 25 MG TABLET 90S, a medication used for the treatment of diabetes. The contract has an ultimate completion date of November 27, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,396.44 firm fixed-price delivery order is for the supply of JARDIANCE 25 MG TABLET 90S, a medication used to treat diabetes. The contract has an ultimate completion date of January 17, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $4,460.95, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JARDIANCE 25 MG TABLET 90S, a pharmaceutical product, with a completion date of January 17, 2025. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,879.33 firm-fixed-price delivery order is for the supply of JARDIANCE 25 MG TABLET 90S, a medication used in the treatment of diabetes. The contract has an ultimate completion date of January 29, 2025 and was awarded on January 28, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,093.08, is for the delivery of JARDIANCE 10 MG TABLET 90S, a prescription medication used for diabetes management. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of January 13, 2025. It is not designated as a set-aside contract....
This federal contract award, valued at $5,383.19, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order for the supply of JARDIANCE 10 MG TABLET 90S, a medication used to treat diabetes. The contract has a Firm Fixed Price pricing type and an ultimate completion date of November 5, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
  • SPE2DB22D1002
    Indefinite Delivery Contract
  • SPE2DB22D1002-SPE2DB25FKXN3
    Delivery Order

This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $4,295.18, is for the delivery of JARDIANCE 10 MG TABLET 90S, a medication used to treat diabetes. The contract is a Firm Fixed Price Delivery Order with a period of performance through February 4, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award did not have any set-aside designations, indicating open competition.

Generated 5/5/25, 9:53 AM